Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | $ 10.83B | $ 23.98B | $ 11.38B | $ 22.00B | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | $ 8.66B | $ 11.27B | $ 13.80B | $ 16.08B | $ 17.34B |
Total Assets | $ 25.78B | $ 29.86B | $ 29.85B | $ 31.24B | $ 29.78B |
Total Debt | $ 6.29B | $ 7.06B | $ 8.45B | $ 10.06B | $ 10.36B |
Net Debt | $ -2.37B | $ -4.20B | $ -5.35B | $ -6.02B | $ -6.98B |
Total Liabilities | - | - | - | - | - |
Stockholders Equity | $ 13.69B | $ 16.63B | $ 15.30B | $ 14.90B | $ 13.86B |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | $ 1.91B | $ 3.91B | $ 1.97B | $ 5.42B | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |